ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 2258 participants.
Also called NCT01424722
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 2,258 participants
- Sponsor
- Registry
-
NCT01424722
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01424722. Allocation not applicable; no masking; primary purpose diagnostic. Start 2011-08 (actual); primary completion 2017-06 (actual). Results posted on 2021-01-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
- Acronym
- AnalyzeST
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01424722- Content hash
68c4668873f6378bad6ece0837608fc3757d5e954b84159f1fe9d36b4f0a5dda